Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	6,052	4,568	4,964	1,449	1,719	1,406
Market Cap Growth	20.92%	-7.98%	242.64%	-15.74%	22.31%	-18.98%
Enterprise Value	5,303	4,051	4,655	1,179	1,436	967
PE Ratio	-	-12.23	-16.81	-5.99	-8.50	-16.74
PB Ratio	7.34	11.27	25.15	7.39	7.17	3.38
P/FCF Ratio	-13.59	-14.02	-22.06	-7.87	-10.89	-33.63
P/OCF Ratio	-13.65	-14.09	-22.08	-7.88	-10.91	-33.77
EV/EBITDA Ratio	-10.18	-11.24	-16.00	-4.88	-7.12	-11.54
EV/EBIT Ratio	-10.17	-11.22	-15.98	-4.88	-7.10	-11.52
EV/FCF Ratio	-11.18	-12.44	-20.68	-6.40	-9.09	-23.15
Debt / Equity Ratio	0.14	0.29	0.25	0.00	0.00	0.00
Debt / EBITDA Ratio	-0.27	-0.33	-0.17	0.00	0.00	-0.01
Debt / FCF Ratio	-0.30	-0.36	-0.22	0.00	0.00	-0.02
Quick Ratio	9.26	5.35	3.10	3.52	6.10	17.47
Current Ratio	9.39	5.38	3.12	3.54	6.13	17.52
Interest Coverage	-30.26	-28.39	-73.51	-	-	-
Return on Equity (ROE)	-128.60%	-219.40%	-270.10%	-100.50%	-64.30%	-18.80%
Return on Assets (ROA)	-78.50%	-98.80%	-123.00%	-79.60%	-56.70%	-18.20%
Return on Capital (ROIC)	-46.90%	-72.82%	-118.72%	-123.15%	-85.84%	-22.76%
Earnings Yield	-7.11%	-8.18%	-5.95%	-16.69%	-11.76%	-5.97%
FCF Yield	-6.26%	-7.13%	-4.53%	-12.71%	-9.18%	-2.97%
Buyback Yield / Dilution	-9.97%	-9.05%	-3.64%	-7.05%	-0.34%	-4.04%
Total Shareholder Return	-9.97%	-9.05%	-3.64%	-7.05%	-0.34%	-4.04%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).